1 / 6

Disposable Medical Gloves Market Size, Share, Development by 2026

Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Various synthetic and biologic products like anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for preventing excessive blood loss or providing adhesion or wound/tissue sealing, and repair of damaged or weakened tissues or bones of a body.

MangeshPanhale
Download Presentation

Disposable Medical Gloves Market Size, Share, Development by 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Biosurgery Market No. of Pages- 115 Global Opportunity Analysis and Industry Forecast, 2014-2022 Download Report Sample

  2. The global biosurgery market is expected to garner $12,758.1 million by 2022, registering a CAGR of 8.1% during the period 2014 - 2022. Hemostatic and surgical sealing agents segment collectively held about half of the market share in 2015, which is expected to flourish over the forecast period. The neuro and spine surgery application segment is likely to lead the biosurgery market throughout the study period. The biosurgery market is projected to grow at a substantial rate owing to rise in sport & spine-related injuries, per capita healthcare expenditure, rise in the number of surgeries due to increase in obese population along with lifestyle disorders and others. Also, availability of multi-functional products would provide a lucrative market opportunity; for instance, apart from fibrins use as surgical sealants, it is also used as hemostatic agents to prevent excessive blood loss during cardiothoracic and orthopedic surgeries. However, factors that would hamper the market growth are high cost associated with surgeries, stern regulatory environment for product approval, and growing popularity of minimally invasive surgeries. Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1235 Biosurgery Market Download Report Sample

  3. The bone graft substitutes segment contributed to one-third share in the overall biosurgery market in 2015. This segment covers products such as cell-based matrices, bone morphogenetic proteins, demineralized bone matrix, and synthetic graft extenders. However, surgical sealant agents segment is expected to grow at the highest growth rate during the forecast period because of the availability of multifunctional products. The neuro- and spine surgery application segment is projected to dominate the market due to high penetration of bone graft substitute products usage in the surgeries. Also, current biologics products are more popular compared to synthetic biosurgical products, and this trend is expected to continue during the analysis period. Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1235 Biosurgery Market Download Report Sample

  4. The Major Key Players Are: • Medtronic PLC • Baxter International Inc. • C. R. Bard Inc. • Johnson and Johnson • Stryker Corporation • Sanofi S.A. • Atrium Medical Corporation (Maquet Getinge Group) • Hemostasis LLC • CryoLife Inc. • Kuros Bioscience. Biosurgery Market Download Report Sample

  5. Key findings of Biosurgery Market: • Surgical sealants are projected to be the fastest growing segment in the biosurgery market with a CAGR of 10.7% from 2015 to 2022. • Hemostatic agents segment is expected to overtake the bone graft substitute segment, and reach $4.3 billion by 2022. • Neuro- and spine surgery application segment is projected to dominate this market throughout the forecast period. • Biologic biosurgical products segment would continue to lead the biosurgery market with about three fourth of the market share in 2015. • Asia-Pacific is projected to be the fastest growing biosurgery market with a CAGR of 10.7% from 2015 to 2022. Biosurgery Market Download Report Sample

  6. Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free (USA/Canada): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Biosurgery Market Download Report Sample

More Related